Proliferating cell nuclear antigen (PCNA) is a 36 kDa protein involved in several cellular mechanisms, including DNA synthesis and repair, cell cycle regulation and apoptosis. An alteration in PCNA structure might contribute to DNA-damage accumulation in cancer cells. This study was aimed to evaluate the PCNA pattern of expression, in terms of aggregation status, isoforms and post-translational modifications, in human hepatocellular carcinoma (HCC) and cirrhosis as well as in HCC cell lines. Twelve HCCs and surrounding cirrhotic tissues were analysed, along with HepG2, Hep3B and SNU-398 cell lines. Normal liver specimens and cirrhosis without HCC were included as controls. Both DNA-bound and DNA-unbound PCNA fractions were analysed, and PCNA pattern of expression was displayed on two-dimensional gel electrophoresis followed by western blot. Results were confirmed by mass spectrometry. To compare HCCs vs surrounding tissues, immunolabelling and immunostaining were performed. In 6 of 12 HCCs and in cell lines, we found three major PCNA acidic forms, corresponding to monomers, probably dimers and trimers, and a basic isoform. In the six remaining HCCs, only a PCNA acidic form associated with multiple basic isoforms was detected. Importantly, the PCNA basic form was not found in cirrhotic tissues. To clarify the nature of the detected PCNA isoforms, ubiquitin-specific immunoblotting as well as phosphatase treatment were employed. A PCNA-ubiquitylated form in cell lines and PCNA-phosphorylated isoforms in 6 of 12 HCCs were detected. Finally, in the DNA-bound fraction we detected only an acidic PCNA monomeric form. We conclude that human hepatocellular carcinoma expresses specific PCNA isoforms compared to those found in cirrhosis, implicating a role for PCNA functional alterations in hepatocarcinogenesis.
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant diseases worldwide, with an increasing incidence expected in the next decades. 1 Unfortunately, no adequate clinical markers are available for HCC diagnosis and prognosis to date, because a-fetoprotein, the serum biomarker routinely used in clinical practice, has a sensitivity of only 50-70%. 2 Progressive accumulation of DNA-damage has been widely reported in preneoplastic and neoplastic hepatic lesions. [3] [4] [5] However, interindividual variability in human DNA-repair capacity, and in posttranslational modifications of the proteins that activate DNA-damage response pathways, is firmly established, 6, 7 and presents a challenge for using DNA damage as a clinical marker.
The proliferating cell nuclear antigen (PCNA) is a 36 kDa protein with a ring-shaped homotrimeric structure that acts as DNA sliding clamp. Both by p53-dependent and -independent regulations, PCNA interacts with multiple proteins that play a key role in DNA-synthesis and repair, cell cycle regulation, chromatin remodelling and apoptosis. [8] [9] [10] [11] [12] Functionally, PCNA may be present in nucleoplasmic-free/ soluble/DNA-unbound and in detergent-resistant/insoluble/ DNA-bound fractions, the latter tightly associated to chromatin and actively involved in DNA-synthesis and repair. [13] [14] [15] Hence, we considered that detailed evaluation of PCNA may provide insights into hepatocarcinogenesis, and may potentially be of value in clinical evaluation of preneoplastic and neoplastic hepatic lesions.
PCNA functions and interactions are modulated by post-translational regulation, whose exact mechanisms are controversial and not completely understood. Several reports have suggested the existence of PCNA modifications, 9, [16] [17] [18] ranging from phosphorylation, 10, 19, 20 not confirmed by others' data, 21, 22 to acetylation 22 and, recently, to methyl esterification. 23 Additionally, PCNA mono and poly-ubiquitylation in response to DNA damage and sumoylation in the absence of damage was described. [24] [25] [26] [27] [28] [29] Other than forming a homotrimeric structure, PCNA also has been found to form double homotrimeric complexes. [30] [31] [32] As each monomer has specific protein binding sites, the polymeric structure allows PCNA to bind different partners suggesting that the aggregation status may be relevant for its functions.
Altogether, the available evidence emphasizes the importance of a proper PCNA structure, to guarantee an efficient association with binding proteins necessary for regular PCNA function. It is conceivable that, in malignant cells, PCNA structure could undergo modulation in the face of the increased DNA-repair activity required by a high genomic instability. Indeed, in breast cancer a specific PCNA isoform was described, termed cancer-specific PCNA, 23, 33, 34 although its functional role is not yet known.
In HCC, PCNA has been found to be overexpressed 35 and functioning in both DNA duplication and DNA-repair. 36 To our knowledge, in HCC and cirrhosis, the detailed PCNA pattern of expression has not been investigated. The present study thus aimed to investigate PCNA expression patterns in HCC, in terms of aggregation status, the presence of isoforms and post-translational modifications. We also sought to evaluate the possible use of PCNA specific forms as a clinically useful malignancy related biomarker. This included correlation of PCNA expression patterns with DNA-synthesis and repair activity, by evaluating both the PCNA-soluble and -insoluble/DNA-bound fractions.
To these purposes, we examined Hep3B, HepG2 and SNU-398 HCC cell lines as well as HCC and matched cirrhotic tissues collected at surgery. As controls, normal liver specimens and cirrhosis without HCC were also included.
MATERIALS AND METHODS Patients and Tissue Collection
HCC and adjacent cirrhotic tissues were collected at surgery from 12 patients subjected to partial hepatectomy for previously untreated HCC (8 males: mean age ± s.d. ¼ 64 ± 7.4 years; 4 females: mean age±s.d. ¼ 71±8.4 years). As controls, a cirrhosis specimen without HCC was obtained after orthotopic liver transplantation and normal liver samplesconfirmed at histopathological examination-were collected after partial hepatectomy for colorectal metastases. Specimens were divided in two parts. One was immediately frozen in liquid nitrogen and stored at À801C. The other was fixed in 10% formalin and paraffin-embedded for histopathological examination and immunohistochemistry. Informed consent was obtained from each patient prior to surgery. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki. For each patient, hepatitis B virus (HBV) and hepatitis C virus (HCV) serum markers were assessed. HBV serum markers were tested by radioimmunoassay test (Abbott commercial kit; Abbott, Chicago, IL, USA). Anti-HCV was tested by second generation ELISA, all positive sera being confirmed by HCV-RNA detection at RT-PCR. Five patients were found to be infected by HBV, five by HCV, one subject was HCV/HBV co-infected and the remaining patient was negative for both viruses. Histopathological grading was assessed according to Edmondson and Steiner criteria. 37 Liver function was assessed according to Child-Pugh score. Study population's characteristics are reported in Table 1 .
Cell Culture Hep3B (HbsAg þ , p53À/À) and HepG2 (virusesÀ, p53 þ / þ ) cell lines (ATCC, Rockville, MD, USA) were maintained in logarithmic growth in minimum essential medium supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St Louis, MO, USA), 50 IU/ml sodium penicillin G and 2 mM L-glutamine. SNU-398 cell line (HbsAg þ ; ATCC), that displays an heterozygous AGT-ATT mutation leading to Ser-Ile substitution in p53 gene, was instead maintained in RPMI medium containing 10% FBS, 100 IU/ml penicillin and 100 U/ml streptomycin. Once 70% confluent, cells were rinsed and scraped into ice-cold phosphate-buffered saline prior to pelletting.
Sample Preparation, Sodium Dodecyl SulphatePolyacrylamide Gel Electrophoresis, Isoelectrofocusing, 2D-PAGE and Western Blot Analysis To perform sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), tissue samples were subjected to mechanical pulverization whereas in dry ice, dissolved by repeated syringing in lysis buffer (10 mM Tris-HCl pH 7.4, 2.5 mM MgCl 2 , 0.5% Triton-X100, 1 mM DTT and protease inhibitors) and centrifuged at 14 000 r.p.m. The supernatants were collected and protein extracts were then analysed according to Laemmli. 38 Briefly, samples were boiled at 951 for 5 min in SDS-loading buffer and electrophoresed on a 12% SDS denaturing gel using Mini Protean apparatus (Bio-Rad Laboratories, Hercules, CA, USA).
For two-dimentional (2D)-PAGE, scraped tissues and cellular pellets were suspended in 1 ml of lysis buffer consisting of 8 M urea, 2 M thiourea, 35 mM Tris, 0.11 M CHAPS, 0.11 M dithioerythritol, 1% carrier ampholytes, bromophenol blue trace (all by Bio-Rad) and a protease inhibitor cocktail (Roche, Mannheim, Germany) and dissolved by repeated syringing. Homogenates were left in lysis buffer for 1 h and centrifuged at 14 000 r.p.m. Supernatants were collected, reduced and alkylated prior to isoelectrofocusing as previously described, 39 lyophilized, resuspended in rehydration buffer and stored at À801C until the isoelectrofocusing procedure. To release the DNA-bound/detergent-insoluble PCNA fraction, neoplastic and cirrhotic sample pellets were digested with DNAse-I as previously reported. 36, 40 The protein content of dialyzed samples was measured using a protein assay kit according to manufacturer's instructions (Bio-Rad).
Passive rehydration of 7 cm, pH 3-10 linear immobilized pH-gradient (IPG) strips (Bio-Rad) was carried out for 12 h at 201C. For cell line samples, available in a most abundant quantity compared to human tissues, in addition to pH 3-10 IPG strips, 7 cm, pH 3.9-5.1 linear IPG strips (Bio-Rad) were also employed, according to the manufacturer's instructions. Isoelectrofocusing was conducted at 201C for 25 000 V hour using a PROTEAN IEF Cell (Bio-Rad). Following isoelectrofocusing, IPG strips were equilibrated for 27 min by rocking in a 375 mM Tris-HCl (pH 8.8), 6 M urea, 20% glycerol and 2% SDS solution.
The second-dimensional separation was performed in 12% polyacrylamide gels without SDS using Mini Protean apparatus (Bio-Rad). Molecular weights (MW) were determined by running standard protein markers, covering the range 250-10 kDa. From each samples, analysed in triplicate, two gels were obtained. One gel was stained with colloidal Bio-Safe s Coomassie (Bio-Rad) for 24 h and the other was electrotransferred onto cellulose nitrate membranes overnight at 50 V, using a Mini Trans-Blot system (Bio-Rad). Membranes were then blocked with 5% non-fatty dry milk in phosphate-buffered saline, washed in phosphate-buffered saline followed by incubation with anti-PCNA monoclonal antibody (clone PC10; Dako, Glostrup, Denmark) opportunely diluted for 90 min at 371C. Proteins were visualized using the enhanced chemiluminescence method (AmershamPharmacia Biotechnology-LKB, Uppsala, Sweden) on photographic slabs (Eastman Kodak, Rochester, NY, USA). The membranes obtained from cell lines samples were then stripped and reprobed overnight with anti-ubiquitin polyclonal antibody (Dako) at 41C.
HCC and cirrhotic protein extracts separated on monodimensional SDS-PAGE were subjected to western blot (WB) analysis for PCNA detection, using the same procedure. Additionally, membranes were stripped and reprobed for 2 h with anti-b-actin monoclonal antibody (Dako), to rule out differences in protein loading. Digital images of autoradiographies were acquired with Fluor-S MultiImager (Bio-Rad) and band signals were quantified in the linear range of the scanner using a densitometric software (QuantityOne; Bio-Rad). Densitometric readings were calibrated against a reference autoradiography and given in relative density units rounded at 0.5 intervals.
Phosphatase Treatment
To dephosphorylate proteins extracted from neoplastic tissues and cell lines, protein samples were treated with phosphatase prior to isoelectrofocusing according to the manufacturer's protocol. Briefly, l-protein phosphatase c Size: Size of the HCC nodules analysed in the study, expressed in mm.
d Nodularity: U, unifocal; M, multifocal.
e AFP: a-Fetoprotein serum level, expressed in ng/ml. 
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A Venturi et al (l-PP) from Upstate (NY, USA) was incubated with protein sample in reaction buffers (50 mM Tris-HCl pH 7.5, 2 mM MnCl 2 , 0.1 mM Na 2 EDTA, 5 mM DTT) for 30 min at 301C. The reaction was then stopped with isoelectrofocusing rehydration buffer. As procedure control, Rb/pRb was used as a phosphoprotein for measuring the activity of l-PP by WB analysis using anti-Rb monoclonal antibody (clone 1F8; LabVision Fremont, CA, USA).
Mass Spectrometry Protein Identification 2D-PAGE and WB membranes were scanned with a Fluor-S MultiImager (Bio-Rad) and analysed using PD-Quest software, version 7.4 (Bio-Rad). The spots corresponding to PCNA at WB analysis were excised from the gel with a razor blade and subjected to in situ digestion as previously described, 41 with some modifications. Briefly, Coomassiestained spots were destained, washed with 100 mM ammonium bicarbonate and acetonitrile (Mallinckrodt Baker, Phillipsburg, NJ, USA), reduced with dithiothreitol and alkylated by iodoacetammide. The gel was incubated for 1 h at 41C in 50 ml of a 12 ng/ml trypsin solution in 50 mM ammonium bicarbonate, pH 8.0. Then, the supernatant was removed and fresh buffer was added to cover gel pieces during the enzymatic cleavage at 371C overnight. The resulting peptides were extracted first with a 1:1 solution of 25 mM ammonium bicarbonate and acetonitrile and then with a 1:1 solution of 5% formic acid and acetonitrile. The extracted tryptic peptides were lyophilized and suspended in 10 ml of 5% formic acid liquid chromatography-mass spectrometry (LC-MS) analysis. High-resolution LC-MS and LC-MS/MS analyses were performed on a Q-TOF premier (Waters, Milford, MA, USA) equipped with a nanospray source. Chromatographic separations were performed on an Atlantis capillary C 18 column (10 Â 0.3 mm; Waters) by means of a 50 min linear gradient from 10-50% CH 3 CN in 1% formic acid, 0.1% TFA. Mass spectra were acquired on a 500-1800 m/z range. The ESI Q-TOF accuracy was calibrated by the external calibration of Glu-Fib (3 p.p.m.). The applied spray voltage was 800-1000 V, with a sample cone of 25-40 V. The MCP detector was at 2250 V, and the energy adjustable collision cell was filled with pure argon gas. MS/MS data processing involved the use of MassLynx 3.5 and data were searched in the NCBInr protein sequence databases using the MS/MS ion search program MASCOT (http://www. matrixscience.com). To obtain the protein identification, peptide had to be in the top hit, with more than two peptide sequences matched. Under less-than-optimal circumstances, a matched protein was accepted if it ranked as the top hit with a single peptide match. In this case (only 4 identities), the MS/MS fragment ion pattern was verified by manual inspection. The manual inspection of MS/MS data processing involved use of the Peptide Sequencing Program with the following strict criteria: (1) MM tolerance was set at 0.3 Da and mass type was assumed to be monoisotopic; (2) the peak threshold was 0.15% and the fragment ion tolerance 0.15 Da; (3) nearly complete Y-ion series and partial complementary B-ion series needed to be present and the Y-ions should correspond to peaks with relatively high intensity.
PCNA Immunohistochemical Assessement
From HCC and surrounding cirrhosis samples, 4-mm-thin sections were cut, collected on 3-ethoxy-aminoethyl-silane treated slides and allowed to dry overnight at 371C. Before immunostaining, sections were microwaved in 10 mM citrate buffer solution pH 6.0 for 20 min at 750 W. After cooling down at room temperature, slides were incubated for 1 h at room temperature with the primary anti-PCNA antibody (clone PC10; Dako) opportunely diluted. The reaction was developed according to a streptavidin-biotin-peroxidase preformed complex (EnVision; Dako) and evidentiated using a peroxidase/DAB enzymatic reaction.
Staining of sections was assessed on 10 consecutive Â 20 magnification fields by two independent observers (AV, CG) using a validated semiquantitative scale where þ is staining of o5% hepatocytes; þ þ , staining of 5-30% hepatocytes and þ þ þ staining on 430% hepatocytes.
RESULTS

2D-PAGE/WB Analysis-Hepatocellular Carcinoma
In HCC samples, 2D-PAGE ( Figure 1 ) coupled with WB analysis revealed the existence of two main different PCNA expression patterns. In the first one (hereafter referred to as pattern 1), detected in all the three cell lines and in 6 of 12 HCCs, three major acidic PCNA forms and a basic isoform were visualized (Figures 2, 3a and 4, left side) .
The main acidic forms, as suggested by MW, correspond to PCNA monomers (36 kDa), and probably dimers (75 kDa) and trimers (110 kDa), because the PCNA dimeric and trimeric structures were stable enough to survive even during isoelectrofocusing and 2D-PAGE processes. 42 In cell lines (Figures 2 and 3a) , a high MW form (220 kDa) was detected at the same acidic pI, probably corresponding to the double trimeric PCNA structure. The spots observed at low MW in both HepG2 and Hep3B cells (near 30, 23 and 15 kDa), could result from PCNA proteolytic degradation (Figure 2b and d) .
The PCNA spots at 36 kDa were actually a cluster of several forms ranging from pI 4.5 to pI 4.65. Possibly depending on higher sample homogeneity, this aspect was more evident in cell lines in which, as confirmed by using narrow pH range IPG strips to increase resolution (Figure 2 , right side), at least 12 forms were evident (pI 4-4.7). These different isoforms may probably be the expression of a post-translational modification. After l-PP treatment, performed to release phosphate groups from phosphoamino acid residues, no modifications were detected, suggesting that the observed isoforms were not due to a phosphorylation process (Figure 3b) .
The basic isoform detected in these samples displayed a significantly high pI ( ¼ 9), with the same MW of PCNA monomer (Figures 2, 3a and 4, left side) . In only one HCC (Figure 4b ), the basic isoform showed a higher MW, near 80 kDa. In five of six tissue samples and in cell lines, it may be possible that the basic isoform was the expression of a high methyl esterification process, that indeed dramatically shifts proteins to basic pI, occurred in the monomeric form. Another post-translational change involving the dimeric form may explain the basic spot observed in the remaining HCC (Figure 4b) .
In HepG2, Hep3B and SNU-398 cell lines, PCNA was present in multiple other modified forms, not detectable in tissue samples (Figures 2 and 3a) . To gain a better understanding of these findings, ubiquitin-specific immunoblotting was performed, detecting a PCNA-ubiquitylated isoform at 42 kDa. The same spot was indeed stained by both anti-PCNA and anti-ubiquitin antibodies (Figure 3a and c) .
In the six remaining HCCs, we identified a different PCNA migration pattern (hereafter referred to as pattern 2), not detected in cell lines. Actually, only a PCNA monomeric acidic form was detected in association with several basic isoforms ( Figure 4, right panel) . Some samples showed the monomeric structure coupled with a more acidic satellite spot (Figure 4d and e) . The PCNA basic isoforms comprised a heterogeneous population of molecules, ranging from 2 ( Figure 4c ) to 7 (Figure 4f) , with MW of 45 kDa and pI ranging from 7 to 7.5. Interestingly, these spots disappeared or seemed to shift to basic spots when protein extracts were incubated with l-PP, indicating that these isoforms were caused by a phosphorylation process (Figure 3d and e) . To verify the efficacy of l-PP treatment, Rb/pRb were used as control (Supplementary Figure 1) .
No statistically significant correlation was found between PCNA isoform pattern of expression in HCCs and a number of clinical-pathological tumour-related variables, including patient's age, viral status, histopathological grade, ChildPugh score, tumour size or PCNA immunostaining (data not shown). Although the two samples with higher a-fetoprotein Figure 1 Representative Coomassie-stained 2D maps of the total sample extracts. Up to 1 mg of proteins extracted from liver cell lines (a: HepG2, b: Hep3B) and tissue specimens (c: hepatocarcinoma, d: cirrhosis) were separated by 2D-PAGE (first dimension, pH 3-10 linear, 7 cm IPG strips; second dimension, 12% homemade polyacrylamide gels without SDS).
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A Venturi et al serum levels displayed PCNA expression pattern 1, no correlation was found between PCNA expression patterns and levels of a-fetoprotein, the only HCC biomarker used in clinical practice. This finding was also supported by the evidence that the analysed cell lines displayed the same PCNA expression pattern but very different a-fetoprotein levels.
2D-PAGE/WB Analysis-Cirrhosis
Among cirrhotic tissues surrounding HCC ( Figure 5 ), 10 of 12 cases displayed only an acidic spot (pI 4.5) corresponding to PCNA at 36 kDa (Figure 5a ). In one sample, a more acidic satellite spot was visualized close to the monomeric PCNA form at the same MW (Figure 5b ). In the remaining sample, PCNA monomeric, probably dimeric and trimeric, forms were detected, without evidence of modified isoforms (Figure 5c ). In addition, the cirrhotic sample without HCC, used as control, displayed only the PCNA monomeric form (Figure 5d ). In none of cirrhotic specimens was a basic PCNA form was demonstrated. Among normal liver samples used as controls (Figure 6 ), one displayed only an acidic spot (pI 4.5) corresponding to PCNA at 36 kDa (Figure 6a) , whereas in the other probably a dimeric form was additionally detected (Figure 6b ).
2D-PAGE/WB Analysis-PCNA DNA-Bound Fraction
After DNAse-I treatment, only an acidic PCNA form was visualized (Figure 7 ), corresponding to the monomer at 36 kDa, pI 4.5. This finding was demonstrated in all the three cell lines (Figure 7a ) and in 7 of 12 HCCs (Figure 7b ), in which a proliferative and/or repair activity was ongoing, as the detection of both nucleoplasmic-free/soluble/DNAunbound and detergent-resistant/insoluble/DNA-bound fractions suggests. Among these seven cases, four showed PCNA expression pattern 1 and the remaining three displayed pattern 2 as PCNA-soluble fraction. In the remaining HCCs, as well as in all the cirrhosis specimens, no DNA-bound PCNA fraction was detected after DNAse-I treatment.
Mass Spectrometry Data
To further confirm the identity of PCNA protein spots visualized by WB, mass spectrometry analyses were carried out.
In these experiments, 4-7 peptides of PCNA sequence were 
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A Venturi et al identified (Table 2 ) and the differences between experimental and theoretical MW of the identified peptides were less then 50 p.p.m. Positive MS PCNA identifications were achieved, analysing both acidic and basic isoforms. In particular, spots at 36 kDa pI 4.5, 4.6 and 9, at 75, 110 and 220 kDa pI 4.5, at 45 kDa pI 7.2 were identified as PCNA. In all the cases, the obtained results led to a sequence coverage ranging from 15 to 28%, satisfactory to achieve an unambiguous protein identification, but lacking of many structural information. A representative PCNA peptide identified is shown in Figure 8 .
WB Analysis And Immunohistochemistry
PCNA expression of the cancerous and surrounding cirrhotic liver was determined by immunoblotting, resulting in specific bands corresponding to 36 kDa. In each case the integrated optical density values were standardized with those of b-actin. PCNA resulted to be upregulated in 9 of 12 HCCs and downregulated in the remaining HCCs compared to matched cirrhosis ( Figure 9 ). However, no statistically significant relationship was found between PCNA levels in HCCs and cirrhotic tissues (P ¼ 0.17 at t-test for independent samples) or between PCNA protein level in HCCs showing PCNA patterns of expression 1 or 2 (P ¼ 0.6 at t-test for independent samples; Figure 10 ). From these results we can rule out the possibility that PCNA expression pattern is related to different total PCNA amount. PCNA immunostaining in cancerous and surrounding cirrhotic liver (Figure 9 ) was selectively localized in the nucleus and mostly in hepatocytes, with few cases showing a faint positivity in fibroblast and biliocytes. According to the semiquantitative scale used, 9 of 12 HCCs showed þ þ þ PCNA immunostaining, 2 cases displayed þ þ immunostaining and the remaining only þ . HCCs displaying PCNA expression patterns 1 and 2 showed a similar PCNA immunostaining (Figure 9 ). (a-c) SNU-398 cell line. 2D-PAGE from SNU-398 cell line was analysed by WB using either anti-PCNA (a) or ubiquitin-specific antibody (c) by stripping and reprobing. In addition to PCNA monomeric, probably dimeric, trimeric and double trimeric forms associated with a basic isoform, a PCNA ubiquitylated form was also found (arrows). (b) A SNU-398 cell sample dephosphorylated prior to 2D-PAGE. No remarkable modification of PCNA pattern of expression was observed. Untreated (d) and dephosphorylated (e) HCC sample showing PCNA expression pattern 2. After l-protein phosphatase treatment PCNA basic isoforms disappeared or seemed to shift to basic spot, indicating that isoforms were caused by a phosphorylation process.
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DISCUSSION
The detection of multiple PCNA isoforms is not a new finding, 9,10,15-20 and post-translational modification is widely thought to be implicated in modulating its function and/or termination of function, in promoting or disrupting protein/ protein interactions and in guiding PCNA to correct partner protein at the correct time. In the present study we analysed, to our knowledge for the first time, PCNA expression in human HCC and cirrhosis in terms of aggregation status, isoforms and post-translational modifications, by using 2D-PAGE/WB and LC-MS. To compare each patient's HCC and cirrhotic tissue, and to investigate as to whether the PCNA patterns of expression may be related to total PCNA protein amount or to different cell types in the tissues, immunolabelling and immunostaining were also performed. As PCNA is regulated through a p53-dependent and independent pathway, 43 HepG2, Hep3B and SNU-398 cell lines were selected to analyse cells with different p53-status. Using this approach, we identified two different PCNA migration patterns and we clearly detected acidic as well as basic PCNA isoforms, according to previous reports. 6, 42 Most notably, isoforms having a basic pI were exclusively found in malignant cells. The PCNA basic isoforms, exclusively detected in hepatic malignant samples, may represent a new signature for neoplastic liver cells compared to cirrhotic tissues.
PCNA isoforms probably do not depend on p53 status, because we obtained similar findings in all the three cell lines despite their different p53 status. Furthermore, different PCNA appearances in cancerous and cirrhotic samples cannot be due to the 2D-PAGE's basic and oxidizing conditions, because all samples were analysed in the same setting, and each in triplicate. We furthermore do not consider that PCNA appearance can be due to artefactual aspects, because cirrhotic or control samples did not display the isoforms detected in HCC and confirmed as PCNA by MS analyses, strongly suggesting a pattern of expression related to the neoplastic transformation. PCNA immunolabelling and immunostaining results also rule out the possibility that PCNA expression pattern is related to different total PCNA protein amount. Additionally, some of the detected forms were close 
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A Venturi et al to the PCNA isoforms previously described. 33, 42 Similar comments can be made about PCNA aggregation status (more clear in Supplementary Figure 2 , when different antibody dilution and exposure times were employed). Indeed, several reports demonstrate that PCNA trimeric structure is stable both on DNA and in solution. 44, 45 Additionally, PCNA was previously detected as dimer and trimer on 2D SDS-PAGE 42 and, more recently, double trimeric structure was described. 31, 32 Our findings therefore agree with those reported in the literature.
As we hypothesized the presence of PCNA post-translational modifications, we studied in more detail the isoforms detected in neoplastic specimens. In particular, by a specific ubiquitin immunoblotting, we detected a ubiquitylated PCNA isoform in cell lines. Accumulating lines of evidence suggest that ubiquitylation plays a role in the regulation of PCNA functions. [24] [25] [26] [27] [28] [29] Ubiquitylation has indeed emerged as an important regulatory switch during DNA replication, and the DNA-damage response specifically involves postreplication DNA repair acting as an error-prone replication safeguard mechanism. 46 Alternatively, mono-ubiquitylation may prevent binding of replication factors to PCNA. 26 In a nonmutually exclusive fashion, such mono-ubiquitylation may attract specific binding partners due to the presence of specific binding motifs. Whatever the exact mechanism, it is interesting to note that PCNA ubiquitylation is conserved from yeast to mammals, suggesting that the functional consequences of this modification might be conserved as well. In HCC cell lines, it is conceivable that the PCNA ubiquitylated form could a pivotal response to the increased DNA repair activity required by high genomic instability and the accumulating DNA-damage in cancer cells. As previously suggested, 42 the detection of a ubiquitylated PCNA isoform may also explain the low MW spots observed in both HepG2 and Hep3B cells as possibly results of PCNA ubiquitin depending proteolytic degradation.
To study more in detail the other isoforms detected in neoplastic specimens, we performed a phosphatase treatment of the samples. In particular, we utilized l-PP because it acts on all currently known phosphoamino acid residues such as phosphoserine, phosphothreonine, phosphotyrosine and phosphohistidine. 47 We detected PCNA phosphorylated isoforms in HCCs showing PCNA expression pattern 2. In the remaining samples, no effect of the treatment was observed. The several PCNA isoforms detected in neoplastic samples compared to non-cancerous tissues might help explain the PCNA overexpression in HCC detected at immunolabelling and immunostaining analysis, and agrees with literature data. 35 Theoretically, a primary role of phosphorylation is to act as a switch to turn 'on' or 'off ' a protein activity or a cellular pathway in an acute and reversible manner. 48 Regarding PCNA in particular, it was recently demonstrated 20 that phosphorylation stabilizes the functional PCNA form during DNA synthesis. As post-translational modifications were demonstrated, it was theoretically possible that such modifications could mask an epitope affecting the PCNA-antibody interaction. However, when two different antibodies against PCNA were employed in a previous study for 2D SDS-PAGE coupled with WB analysis 42 (PC10 monoclonal and C-20 polyclonal anti-PCNA antibodies), the same results were obtained and no additional PCNA spots were detected.
The variant PCNA isoforms detected, including ubiquitylated and phosphorylated ones, might be regarded as a part of a continuum that extends from benign to malignant tissue, due to the increasing DNA synthesis and repair activity in cancer cells. It also seems plausible that distinct pools of PCNA might act simultaneously and in concert, to accomplish different roles within different metabolic pathways, as recently suggested. 12 Alternatively, PCNA may shift from acidic to basic isoforms through the cell cycle phases and the 2 and 4) . b-Actin was analysed to rule out differences in protein loading. Abbreviation: LC, matched liver cirrhosis.
A Venturi et al relative amounts of the different isoforms may vary during the cell cycle. Lastly, after DNAse-I treatment, performed in order to release the PCNA detergent-insoluble fraction to verify if one or more of the basic isoforms previously detected in neoplastic samples were chromatin bound, only an acidic monomeric PCNA was observed. These data suggest that either DNA-bound PCNA post-translational modifications are too low to be detected by this kind of analysis or modified isoforms are spontaneously hydrolysed by the procedure of DNAse-I treatment, leaving an unmodified form.
The need to identify new diagnostic and prognostic HCC biomarker is still urgent. This study demonstrates that, by combining 2D-PAGE with WB analysis, it is possible to detect two main PCNA expression patterns in human liver tumours and cell lines, as well as PCNA isoforms specifically expressed in neoplastic samples. In PCNA expression pattern 1, at least three different main acidic forms and a basic isoform of PCNA were detected. A PCNA ubiquitylated form also is demonstrated in this expression patter. In pattern 2, PCNA was present in an acidic form associated with several basic phosphorylated isoforms. Most notably, in none of cirrhotic tissues was a PCNA basic spot was detected. These data show that PCNA is differently expressed in HCC and cirrhotic tissues, in terms of structure, isoforms and post-translational modifications, strongly implicating functional alterations in PCNA in the hepatocancerogenetic process. Future in vitro experiments will hopefully provide further information on the functional consequences of PCNA modifications, first of all ubiquitylation and phosphorylation, in the development of HCC. 
